Core Viewpoint - Kyndryl Holdings, Inc. is under investigation for potential securities fraud following a significant stock drop of over 52% due to an accounting review and the departure of key executives [1][1][1] Group 1: Investigation Details - The investigation is being conducted by Bleichmar Fonti & Auld LLP to determine if Kyndryl misrepresented its cash management practices and the drivers of its adjusted free cash flow metric [1][1] - The inquiry focuses on Kyndryl's internal controls over financial reporting for FY2025 and the first three quarters of FY2026 [1][1] Group 2: Stock Performance - Kyndryl's stock price fell by more than 52% on February 9, 2026, following the announcement of a delay in the release of its fiscal Q3 2026 financial statement due to an accounting review [1][1] - The stock drop was exacerbated by the immediate departures of the CFO and General Counsel [1][1]

Core Viewpoint - Ademi LLP is investigating potential securities fraud claims against Stellantis N.V. due to possibly inaccurate statements regarding its business operations and future prospects [1] Group 1: Investigation Focus - The investigation centers on whether Stellantis has been experiencing "poor operational execution" in its strategy to boost sales of electric vehicles [1] - Concerns are raised about the quality control of Stellantis' manufacturing processes [1] Group 2: Legal Context - Ademi LLP specializes in securities fraud and shareholder litigation, indicating a focus on protecting shareholder interests [1] - The investigation is being conducted without any cost or obligation to participants [1]

Brad Karp built Paul Weiss into a legal powerhouse. Years of chummy emails with Jeffrey Epstein cost him his job. https://t.co/jZ00FM2Q7C ...

Core Viewpoint - Ramaco Resources, Inc. is facing a class action lawsuit due to allegations of securities fraud related to misleading statements about its Brook Mine operations, which were claimed to be non-existent or exaggerated during the specified class period [1]. Group 1: Lawsuit Details - The class action lawsuit is filed on behalf of investors who purchased Ramaco securities between July 31, 2025, and October 23, 2025 [1]. - The lawsuit alleges that Ramaco made materially false and misleading statements regarding the commencement and progress of mining activities at the Brook Mine [1]. - The report from Wolfpack Research claims that no significant mining activity occurred at the Brook Mine after its groundbreaking, leading to a significant drop in Ramaco's stock price by $3.81, or 9.6%, to close at $36.01 per share on October 23, 2025 [1]. Group 2: Allegations Against the Company - The lawsuit claims that Ramaco failed to disclose that no active work was taking place at the Brook Mine, which misled investors about the company's operational status [1]. - It is alleged that the company overstated development progress at the Brook Mine, which contributed to the misleading nature of its positive statements about business prospects [1]. - The lawsuit emphasizes that the defendants' statements lacked a reasonable basis, further compounding the misleading information provided to investors [1].

Core Viewpoint - Robbins LLP has announced a class action lawsuit against Picard Medical, Inc. for alleged fraudulent stock promotion activities that misled investors [1] Group 1: Allegations Against Picard Medical, Inc. - The lawsuit claims that Picard Medical was involved in a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals [1] - It is alleged that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [1] - The company's public statements and risk disclosures reportedly omitted any mention of false rumors and artificial trading activity that influenced the stock price [1] Group 2: Stock Price Impact - On October 24, 2025, Picard Medical's stock price fell sharply by 70%, dropping to $3.99 per share [1] - Following the initial crash, the stock price has continued to decline, reaching approximately $2.00 per share [1] Group 3: Class Action Participation - Investors who purchased Picard Medical securities between September 2, 2025, and October 31, 2025, may be eligible to participate in the class action [1] - Shareholders wishing to serve as lead plaintiff must file their papers with the court by April 3, 2026 [1] - Participation in the case is not required to be eligible for recovery, allowing investors to remain absent class members if they choose [1]

Core Viewpoint - Kahn Swick & Foti, LLC is investigating the proposed sale of SkyWater Technology, Inc. to IonQ, focusing on the adequacy of the price and the process leading to the transaction [1] Group 1: Proposed Transaction Details - Under the terms of the proposed sale, shareholders of SkyWater will receive $15.00 in cash and $20.00 in shares of IonQ common stock for each share of SkyWater owned [1] - The investigation aims to determine if the consideration offered undervalues SkyWater Technology [1] Group 2: Legal Inquiry - Kahn Swick & Foti, LLC is seeking to assess the adequacy of the proposed transaction and the process that led to it [1] - Shareholders who believe the transaction undervalues the company are encouraged to discuss their legal rights with KSF [1]

Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the sale of Stellar Bancorp, Inc. to Prosperity Bancshares, Inc. for 0.3803 shares of Prosperity common stock and $11.36 in cash per share of Stellar common stock, focusing on whether the transaction is fair to Stellar shareholders [1]. Group 1: Investigation Details - The investigation aims to determine if Stellar Bancorp and its board violated federal securities laws or breached fiduciary duties by not securing the best possible consideration for shareholders [1]. - Key concerns include whether Prosperity is underpaying for Stellar and if all material information necessary for shareholders to assess the merger consideration has been disclosed [1]. Group 2: Legal Representation - Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures, and other relief related to the proposed transaction [1]. - The firm operates on a contingent fee basis, meaning shareholders would not incur out-of-pocket legal fees or expenses [1].

Core Insights - Citigroup Inc. is a leading global financial services company operating in over 160 countries, providing a wide range of financial products and services [1] - The company's stock was upgraded to "Overweight" with a price of $111.73, reflecting confidence in its performance and the economic outlook for 2026 [2][6] - The 2026 Citi Hildebrandt Client Advisory indicates an 11.3% revenue growth in the legal industry for 2025, positively impacting Citigroup's wealth management division [3][5][6] - Citigroup's market capitalization is approximately $207.9 billion, with a significant trading volume of 7,683,053 shares, indicating strong investor interest [4][6] Company Performance - The stock price of Citigroup has shown a slight increase of 0.58%, fluctuating between $111.11 and $112.34 on the day of the upgrade [2] - The highest stock price over the past year was $112.34, while the lowest was $55.51, showcasing the stock's volatility [4] Industry Outlook - The positive outlook for the legal industry, as reported in the Citi Hildebrandt Client Advisory, suggests continued growth opportunities for Citigroup's wealth management division [5]

Core Viewpoint - Rezolute, Inc. is currently under investigation for potential securities fraud violations, which may impact its financial standing and investor confidence [1] Group 1 - The investigation is being conducted by the DJS Law Group, indicating potential legal ramifications for the company [1] - Investors are encouraged to discuss their rights in light of the ongoing investigation, suggesting that there may be significant implications for shareholders [1]

What does an agentic uh workflow look like for legal and for Harvey. >> I would think of there's kind of two ends of this spectrum that we think about when we think of building this in the product. One is how do you do the very open-ended agentic tasks.So if you give Harvey any question you would give an associate, can we have some system that kind of looks like deep research that can take that task, create some plan, figure out which tools to use and solve this. And then the other end of the extreme is a l ...